Enveric Biosciences Files 8-K on Financials
Ticker: ENVB · Form: 8-K · Filed: Mar 31, 2025 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Enveric Biosciences dropped its Q1 2025 8-K. Check financials.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on March 31, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company incorporated in Delaware and headquartered in Naples, Florida.
Why It Matters
This filing provides investors with updated financial information and operational results for Enveric Biosciences, Inc.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- March 31, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- Naples, FL (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Enveric Biosciences, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on March 31, 2025.
Where is Enveric Biosciences, Inc. headquartered?
Enveric Biosciences, Inc.'s principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
In which state was Enveric Biosciences, Inc. incorporated?
Enveric Biosciences, Inc. was incorporated in Delaware.
What is the Commission File Number for Enveric Biosciences, Inc.?
The Commission File Number for Enveric Biosciences, Inc. is 001-38286.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Enveric Biosciences, Inc. (ENVB).